Corbus Pharmaceuticals Alternatives & Competitors
12 companies similar to Corbus Pharmaceuticals — Committed to leveraging expertise in immunology to fulfill purpose of developing...
Companies similar to Corbus Pharmaceuticals
Apexigen
Creating Transformative Immunotherapies for Patients with Cancer
San Carlos, United States
Chemomab Therapeutics
Developing innovative therapeutics for diseases at confluence of fibrosis and inflammation...
Israel
Redx Pharma
Biotech company focusing on the discovery and development of novel targeted medicines to t...
United Kingdom
Upstream Bio
Developing treatments for inflammatory diseases
Waltham, United States
Track all Corbus Pharmaceuticals competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
ImmunoMet Therapeutics, Inc.
Targeting Metabolic Reprogramming in Fibrosis and Oncology
Poolbeg Pharma plc
Focused on the development & commercialisation of innovative medicines. Ticker: POLB
London, United Kingdom
Immutep Limited
The global leader in developing LAG-3 therapeutics (ASX: IMM, NASDAQ: IMMP)
Australia
OSE Immunotherapeutics
Immuno-Oncology and Immuno-Inflammation - Breakthrough Immuno-Science for Patients
Nantes, France
TNF Pharmaceuticals, Inc.
TNF Pharmaceuticals is a clinical stage pharmaceutical company committed to extending a he...
Baltimore, United States
Tagworks Pharmaceuticals
Pioneer of Click-to-Release chemistry; designing more effective and safer systemic therapi...
Nijmegen, The Netherlands
Syntara
Syntara (ASX:SNT) is an ASX-listed clinical stage drug developer for diseases linked to fi...
Australia
Elevation Oncology
We are focused on discovering and developing selective cancer therapies to treat patients...
Boston, United States
About Corbus Pharmaceuticals
Corbus Pharmaceuticals is a precision oncology startup committed to leveraging expertise in immunology to develop innovative new medicines. The company's internal development pipeline includes CRB-701, a next-generation antibody drug conjugate (ADC) targeting the expression of Nectin 4 on cancer cells, and CRB-601, an...
Precision Oncology, Cancer Immunotherapy, Antibody Drug Conjugate, TGFβ Inhibition, Endocannabinoid System, CB2 Agonist, Inflammatory Diseases, Fibrotic Diseases, Lenabasum, Fibrosis Resolution, Systemic Sclerosis, Cystic Fibrosis, Dermatomyositis, NASH, Phase 3 Clinical-stage Pharmaceutical Company
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Corbus Pharmaceuticals and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Corbus Pharmaceuticals on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
